October 9, 2014—Brand-name drug manufacturers filed suit in federal district court today seeking to invalidate the 340B orphan drug exclusion interpretative rule.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register.
Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)